Author name: abldadmin

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the execution of an exclusive distribution agreement to confer to AB ANALITICA (https://www.abANALITICA.com/en/) the rights to promote and commercialize ABLD assays and software systems to all laboratories

Newburyport (MA, USA) – AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the opening of its new temperature-controlled warehouse in the USA, to offer its clients and partners improved quality and

INTRODUCING THE DEEPCHEK GENOTYPING TECHNOLOGY OVERVIEW & USERS EXPERIENCE Webinar from Tuesday January 30, 2024 – 4pm CET Revue de la Solution DeepChek Genotyping à travers un Webinaire présenté par notre équipe et par un panel d’experts :

REVUE DE LA TECHNOLOGIE DE GENOTYPAGE DEEPCHEK PRESENTATION & EXPERIENCES UTILISATEUR Webinaire réalisé le mardi 23 janvier 2024 – 10h00 CET Revue de la Solution DeepChek Genotyping à travers un Webinaire présenté par notre équipe et par un panel d’experts :

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the release of new versions of its CE-IVD (In Vitro Diagnostics) DeepChek® and ViroScore® software applications (v3.30.115-ivdr). Tailored to analyze Next Generation Sequencing (NGS) and Capillary Electrophoresis

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce the expansion of its HIV genotyping menu of applications with the release of a new revolutionary assay, DeepChek® Assay HIV-1 Full PR/RT/INT Drug Resistance. The company keeps innovating

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the expansion of its network of exclusive distributors, able to offer the DeepChek® technology to laboratories willing to implement microbiology applications like HIV, SARS-CoV-2, Tuberculosis, Cytomegalovirus, Viral